Global Nephrology and Urology Devices Market
Publish Date:
Sep 2026
|
Report ID:
DAR5343
|
Format:
|
Author:
Disha B
|
Pages:
210
|
Author:
Disha B
|
Pages:
210
Global Nephrology and Urology Devices Market Size, Share By Product (Ureteral Catheters, PCN Catheters, Urinary Stents, Urology Guidewires, Stone Basket, Renal Dilators, and Others), By Application (Urolithiasis, Urological Cancer & BPH, Bladder Disorders, Kidney Diseases, and Others), By End Use (Hospitals, Ambulatory Surgical Centers, Clinics, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Analysis and Forecast 2026-2035.
CAGR
6.72%
REVENUE 2025
USD Billion 8.43
FORECAST 2035
USD Billion 16.15
REPORT COVERAGE
Global
The Global Nephrology and Urology Devices Market Size is predicted to grow from 8.43 Billion in 2025 and is likely to reach around USD 16.15 Billion by 2035 with a CAGR of 6.72%. According to Decision Advisors, a detailed research report on the market reflects that the touchless sensing adoption trend dominates the Global Nephrology and Urology Devices Market, accounting for approximately 32% of the total share worldwide. Boston Scientific Corporation is among the leading contributors to the market, with its Urology business reporting net sales of approximately USD 1.96 billion, approximately 14% global market share, making it the key contributor to global market development and growth dynamics.
Market Snapshot
-
Global Nephrology and Urology Devices Market Size (2025): USD 8.43 Billion
-
Projected Global Nephrology and Urology Devices Market Size (2035): USD 16.15 Billion
-
Global Nephrology and Urology Devices Market Compound Annual Growth Rate (CAGR): 6.72%
-
Largest Regional Market: Asia Pacific
-
2nd Largest Region: North America
-
Fastest Growing Region: Europe
-
Base Year: 2025
-
Historical Period: 2021-2024
-
Market Forecast Period: 2026-2035
Market Overview/ Introduction
The Global Nephrology and Urology Devices Market refers to the industry that develops instruments, consumables and equipment used to diagnose, treat and manage disorders of the kidneys and urinary system, including chronic kidney disease, kidney stones (urolithiasis), benign prostatic hyperplasia (BPH), urinary incontinence and urological cancers. The market is experiencing substantial growth because of the rising global burden of kidney disease, the expansion of dialysis treatment infrastructure, and increasing adoption of minimally invasive endourological procedures. Government programs such as the U.S. CDC Chronic Kidney Disease Initiative, Japan's national kidney disease control measures and China's universal health coverage reforms are creating better conditions for early diagnosis, treatment access and device adoption. Key companies, including Medtronic, Boston Scientific, Coloplast, B. Braun and Fresenius Medical Care, are developing advanced catheters, stents, lithotripsy systems and robotic-assisted platforms that combine higher precision with reduced procedure times and improved patient comfort. The global market will experience future expansion through the development of AI-enabled diagnostics, home-based and portable dialysis systems, robotic-assisted urologic surgery and single-use endoscopic devices.
-
The U.S. CDC's Chronic Kidney Disease Initiative funds national surveillance and early-detection programs, supporting greater use of diagnostic and monitoring devices for kidney disease across the country.
-
-
Japan's Ministry of Health, Labour and Welfare has pursued national kidney disease control measures since 2018, promoting early referral and screening that is expanding demand for nephrology diagnostic and dialysis devices.
Notable Insights: -
-
Asia Pacific is anticipated to hold approximately 38% share of the Global Nephrology and Urology Devices over the predicted timeframe.
-
North America is expected to grow at a rapid CAGR Global Nephrology and Urology Devices Market holding approximately 32% of the share during the forecast period.
-
By product, the Others segment dominated the market and held approximately 28% share in 2025 and is projected to grow at a substantial CAGR during the forecast period.
-
By application, the Urolithiasis segment dominated the market and holds approximately 44% share in 2025 and is projected to grow at a substantial CAGR during the forecast period.
-
The compound annual growth rate of the Global Nephrology and Urology Devices Market is 6.72%.
-
The market is likely to achieve a valuation of USD 16.15 Billion by 2035.
Market Drivers
The Global Nephrology and Urology Devices Market experiences growth because of the rising global prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), which is increasing demand for dialysis machines, catheters and vascular access devices. The growing incidence of kidney stones and urolithiasis is driving greater use of ureteroscopes, lithotripters and stone-retrieval devices in endourological procedures. The rising burden of benign prostatic hyperplasia (BPH), urinary incontinence and urological cancers among an aging population further expands demand for stents, slings and minimally invasive surgical systems. Increasing adoption of robotic-assisted surgery and AI-enabled diagnostic tools is improving procedural accuracy and reducing recovery times, encouraging hospitals and ambulatory surgical centers to upgrade equipment. Rising healthcare expenditure, expanding dialysis center networks and growing insurance coverage for renal and urological care in emerging economies are also supporting market expansion.
Restrain
The Global Nephrology and Urology Devices Market faces challenges such as the high cost of advanced dialysis and robotic-assisted devices, coupled with limited reimbursement for these procedures in several developing economies. A shortage of skilled nephrologists, urologists and trained dialysis technicians in many countries may also limit the adoption of advanced technologies, while the risk of device-related complications such as catheter-associated infections continues to be a concern for manufacturers and clinicians.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the Global Nephrology and Urology Devices Market along with a comparative evaluation primarily based on their product offerings, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top 10 Companies in the Global Nephrology and Urology Devices Market
-
Medtronic plc
-
Boston Scientific Corporation
-
Coloplast A/S
-
B. Braun SE
-
Teleflex Incorporated
-
Baxter International Inc.
-
Fresenius Medical Care AG & Co. KGaA
-
Olympus Corporation
-
Cook Group Incorporated
-
Hollister Incorporated
Government Initiatives
|
Country
|
Key Government Initiatives
|
|
US
|
The CDC's Chronic Kidney Disease (CKD) Initiative funds national surveillance through NHANES and supports early-detection and awareness programs, driving greater adoption of diagnostic and monitoring devices for kidney disease across U.S. healthcare systems.
|
|
Japan
|
The Ministry of Health, Labour and Welfare's national kidney disease control measures, in place since 2018, promote early referral from primary care to nephrology specialists, supporting growing demand for diagnostic, screening and dialysis-related devices.
|
|
China
|
Government policies expanding universal health coverage and merging urban-rural insurance systems are improving affordability and access to kidney replacement therapy, boosting adoption of dialysis equipment and nephrology devices nationwide.
|
Market Segmentation
The Global Nephrology and Urology Devices Market share is classified into product, application and end use
-
The Others segment dominated the market and holds approximately 28% share in 2025 and is projected to grow at a substantial CAGR during the forecast period.
Based on product, the Global Nephrology and Urology Devices Market is divided into Ureteral Catheters, PCN Catheters, Urinary Stents, Urology Guidewires, Stone Basket, Renal Dilators, and Others. Among these, the Others segment dominates the market and holds approximately 28% share in 2025. This dominance is due to the broad range of ancillary accessories used across dialysis and endourological procedures, along with steady replacement demand from hospitals and dialysis centers. Percutaneous nephrostomy (PCN) catheters represent the fastest-growing product segment, supported by their expanding use in renal transplant complications and obstructive uropathy management.
-
The Urolithiasis segment accounted for the largest share of approximately 44% in 2025 and is anticipated to grow at a significant CAGR during the forecast period.
Based on application, the market is divided into Urolithiasis, Urological Cancer & BPH, Bladder Disorders, Kidney Diseases, and Others. Among these, Urolithiasis accounted largest share of approximately 44% in 2025 and is anticipated to grow at a significant CAGR during the forecast period. This dominance is due to the rising global incidence of kidney stones linked to dietary patterns, dehydration and metabolic disorders, which continues to drive demand for ureteroscopes, guidewires and stone-retrieval devices. The Kidney Diseases segment is expected to be the fastest-growing application, supported by the rising burden of chronic kidney disease and end-stage renal disease worldwide.
-
The Hospitals segment accounted for the largest share of approximately 46% in 2025 and is anticipated to grow at a significant CAGR during the forecast period.
Based on end use, the market is divided into Hospitals, Ambulatory Surgical Centers, Clinics, and Others. Among these, Hospitals dominate the market largest share of approximately 46% in 2025 and is anticipated to grow at a significant CAGR during the forecast period due to the high volume of nephrology and urology procedures, availability of specialized departments and advanced diagnostic capabilities. Ambulatory Surgical Centers (ASCs) are expected to register the fastest growth, driven by the shift toward outpatient and minimally invasive procedures.
Regional Segment Analysis of the Global Nephrology and Urology Devices Market
-
North America (U.S., Canada, Mexico)?
-
Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
-
Asia-Pacific (China, Japan, India, Rest of APAC)
-
South America (Brazil and the Rest of South America)?
-
The Middle East and Africa (UAE, South Africa, Rest of MEA)
Asia Pacific is anticipated to hold approximately 38% share of the Global Nephrology and Urology Devices over the predicted timeframe.
Asia Pacific is anticipated to hold approximately 38% share of the Global Nephrology and Urology Devices Market during the forecast period and is expected to record the fastest CAGR. Market growth is driven by a rapidly aging population, increasing prevalence of diabetes and hypertension-related kidney disorders, and expanding healthcare infrastructure across China, Japan, and India. Rising government investments in dialysis facilities and kidney disease management are strengthening access to essential treatment solutions. Additionally, growing awareness of early screening and diagnosis, improving healthcare expenditure, and increasing affordability of medical technologies are supporting device adoption. The region's expanding hospital networks, increasing demand for minimally invasive urological procedures, and growing availability of advanced diagnostic and treatment technologies are expected to further accelerate market expansion throughout the forecast period.
North America is expected to grow at a rapid CAGR Global Nephrology and Urology Devices Market holding approximately 32% of the share during the forecast period.
North America is expected to maintain a strong position in the Global Nephrology and Urology Devices Market, holding approximately 32% share during the forecast period. The region's market leadership is supported by well-established healthcare infrastructure, a high prevalence of chronic kidney disease and urological disorders, and the presence of leading medical device manufacturers. Favorable reimbursement policies, high healthcare expenditure, and increasing adoption of robotic-assisted and minimally invasive technologies further support market growth. Additionally, ongoing investments in dialysis center networks and the rising preference for home-based renal care are creating new opportunities for nephrology device providers. Increasing demand for advanced diagnostic, monitoring, and treatment solutions is expected to reinforce North America's market position throughout the forecast period.
Europe is the fastest-growing region in the Global Nephrology and Urology Devices Market during the period, holding approximately 23% share.
Europe is expected to be the fastest-growing region in the Global Nephrology and Urology Devices Market, holding approximately 23% share during the forecast period. The region maintains the second-largest market position, supported by well-established healthcare systems, an aging population, and increasing prevalence of kidney and urological disorders. Rising demand for advanced dialysis equipment, diagnostic technologies, and urological treatment solutions in countries such as Germany, France, and the U.K. is supporting market growth. Strict regulatory standards and increasing adoption of minimally invasive endourology procedures are further strengthening demand for advanced devices. Additionally, growing investments in digital health infrastructure, home-based care, and modern healthcare facilities are expected to create significant opportunities for nephrology and urology device manufacturers across Europe.
Future Market Trends in Global Nephrology and Urology Devices Market: -
-
Expansion of Robotic-Assisted and AI-Enabled Urology Procedures
Robotic-assisted platforms and AI-enabled diagnostic tools are improving surgical precision, reducing complication rates and shortening recovery times in urologic cancer, BPH and stone-management procedures. Growing clinician training and expanding robotic installations in hospitals are accelerating adoption globally.
-
Growth of Home-Based and Portable Dialysis Systems
Compact, easy-to-use hemodialysis and peritoneal dialysis systems are enabling patients to manage chronic kidney disease from home, reducing hospital visits and improving quality of life. Rising patient preference for decentralized care is driving strong demand for portable dialysis technology.
-
Rising Adoption of Single-Use and Disposable Endoscopic Devices
Single-use cystoscopes, ureteroscopes and related endourology devices are gaining traction due to reduced infection risk, elimination of reprocessing costs, and consistent performance. Hospitals and ambulatory surgical centers are increasingly shifting toward disposable device portfolios.
-
Integration of Digital Health and Remote Patient Monitoring in Kidney Care
Connected dialysis machines, wearable sensors and remote monitoring platforms are enabling continuous tracking of kidney function and treatment adherence. This trend is improving early intervention capabilities and supporting value-based, patient-centered renal care models.
Recent Development
-
In November 2024, Boston Scientific Corporation completed its acquisition of Axonics, Inc., strengthening its portfolio in sacral neuromodulation devices for urinary and bowel dysfunction.
-
In September 2025, Olympus Corporation launched its OLYSENSE CAD/AI portfolio in the U.S. and Europe, introducing AI-powered computer-aided detection tools designed to support earlier detection during endoscopic procedures.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Decision Advisors has segmented the Global Nephrology and Urology Devices Market, based on the below-mentioned segments:
Global Nephrology and Urology Devices Market, By Product
-
Ureteral Catheters
-
PCN Catheters
-
Urinary Stents
-
Urology Guidewires
-
Stone Basket
-
Renal Dilators
-
Others
Global Nephrology and Urology Devices Market, By Application
-
Urolithiasis
-
Urological Cancer & BPH
-
Bladder Disorders
-
Kidney Diseases
-
Others
Global Nephrology and Urology Devices Market, By End Use
-
Hospitals
-
Ambulatory Surgical Centers
-
Clinics
-
Others
Global Nephrology and Urology Devices Market, By Regional Analysis
-
North America
-
US
-
Canada
-
Mexico
-
-
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Rest of Europe
-
-
Asia Pacific
-
China
-
Japan
-
India
-
South Korea
-
Australia
-
Rest of Asia Pacific
-
-
South America
-
Brazil
-
Argentina
-
Rest of South America
-
-
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of the Middle East & Africa
-
Frequently Asked Questions (FAQ)
Q. Which application segment dominates the market?
A. The Urolithiasis segment held the largest revenue share in 2025 due to the rising global incidence of kidney stones, while the Kidney Diseases segment is expected to grow fastest.
Q. Who are the key players in the Global Nephrology and Urology Devices Market?
A. Key players include Medtronic, Boston Scientific Corporation, Coloplast, B. Braun, Teleflex, Baxter, Fresenius Medical Care, Olympus, Cook Group, and Hollister Incorporated.
Q. What are the major drivers of the market?
A. Growth is driven by the rising prevalence of chronic kidney disease and urological disorders, expanding dialysis infrastructure, increasing minimally invasive and robotic-assisted procedures, and growing adoption of AI-enabled diagnostic tools.
Q. What is the largest end-use segment in the Global Nephrology and Urology Devices Market?
A. The Hospitals segment accounted for the largest share in 2025, supported by high procedure volumes, specialized nephrology and urology departments, advanced diagnostic equipment, and comprehensive treatment capabilities.
Q. What factors are increasing demand for nephrology devices?
A. Demand is increasing due to the rising prevalence of chronic kidney disease, diabetes, hypertension, and end-stage renal disease, along with expanding dialysis infrastructure and greater awareness of early kidney disease diagnosis.
Check Licence
Choose the plan that fits you best: Single User, Multi-User, or Enterprise solutions tailored for your needs.
We Have You Covered
- 24/7 Analyst Support
- Clients Across the Globe
- Tailored Insights
- Technology Tracking
- Competitive Intelligence
- Custom Research
- Syndicated Market Studies
- Market Overview
- Market Segmentation
- Growth Drivers
- Market Opportunities
- Regulatory Insights
- Innovation & Sustainability
Report Details
| Scope | Global |
| Pages | 210 |
| Delivery | PDF & Excel via Email |
| Language | English |
| Release | Sep 2026 |
| Access | Download from this page |